CD4 Antibody [CE9.1 (Clenoliximab) ], Human IgG4 - Research Grade Biosimilar

• Other Statements:

  NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques.

• NCBI Gene ID:

  920

• Swiss Prot:

  P01730

• Reactivity:

  Human, chimpanzee

• Immunogen:

  Domain 1 of human CD4.

• Clonality:

  Recombinant Monoclonal

• Clone:

  CE9.1 (Clenoliximab)

• Conjugation:

  Unconjugated

• Type:

  Primary Antibodies, Biosimilars

• Field of Research:

  Immunology, Other

• Concentration:

  Batch dependent

• Buffer:

  PBS with 0.02% Proclin 300.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at -20⁰C.

• Fragment:

  IgG4 lambda

• Symbol:

  CD4

• NCBI Official Name:

  HGNC:HGNC:1678

• NCBI Organism:

  Homo sapiens

• Other Product Names:

  P55, T cell surface antign T4/Leu-3.

• Tested Applications:

  ELISA, Flow, Blocking, Surface Plasma Resonance, IHC

• Species:

  Human